Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12297267 | Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor | Zhao Wu, Zhigang Liu, Lei Xiao, Chengfei Pu | 2025-05-13 |
| 12240915 | Chimeric antigen receptor cells for treating solid tumor | Lei Xiao, He Sun, Wensheng Wang, Chengfei Pu, Li Mao | 2025-03-04 |
| 12150960 | Modified cell expansion and uses thereof | Lei Xiao, Chengfei Pu, He Sun | 2024-11-26 |
| 12076343 | Engineered safety in cell therapy | Chengfei Pu, Zhao Wu, Lei Xiao | 2024-09-03 |
| 11981920 | Modified cell with enhanced migration capability | Chengfei Pu, Lei Xiao, He Sun | 2024-05-14 |
| 11970548 | Nanobody target GCC and uses in chimeric antigen receptor cell therapy | Yuzhe Peng, Lei Xiao, Zhao Wu, Le Tian | 2024-04-30 |
| 11944645 | Modified cell and use thereof in gene and cell therapy | Lei Xiao, Yuzhe Peng, Wei Ding, Wensheng Wang | 2024-04-02 |
| 11932700 | Use of chimeric antigen receptor modified cells to treat cancer | Lei Xiao, Chengfei Pu, He Sun, Mao Bi, Zhao Wu | 2024-03-19 |
| 11866494 | CAR T therapy through uses of co-stimulation | Chengfei Pu, Lei Xiao, Zhao Wu | 2024-01-09 |
| 11833174 | Modified cell with enhanced functionality and cellular therapy thereof | Chengfei Pu, Dongqi Chen, Wei Ding | 2023-12-05 |
| 11834502 | Reducing immune inhibition induced by SIGLEC-15 | Chengfei Pu, Lei Xiao | 2023-12-05 |
| 11823118 | Models for early detection of delivery defects—unassigned delivery blocks | Minghao Gai, Leah Autumn Thompkins, Arun Kumar Galba | 2023-11-21 |
| 11739136 | Inducible dominant negative PD-1 and uses in adoptive cell therapy | Chengfei Pu, Lei Xiao | 2023-08-29 |
| 11701385 | Modulation of cell function for immunotherapy | Chengfei Pu, Lei Xiao, Zhao Wu | 2023-07-18 |
| 11633427 | Vaccine and uses thereof in cell therapy | Yang Li, Wei Ding, Xianyang Jiang, Chengfei Pu, Le Tian +3 more | 2023-04-25 |
| 11566223 | Chimeric antigen receptor cell preparation and uses thereof | Lei Xiao, Chengfei Pu, Zhao Wu | 2023-01-31 |
| 11364289 | Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor | Zhao Wu, Zhigang Liu, Lei Xiao, Chengfei Pu | 2022-06-21 |
| 11235004 | Lymphocyte cell lines and uses thereof | Lei Xiao, Chengfei Pu, Zhao Wu | 2022-02-01 |
| 11161913 | Chimeric antigen receptor cells for treating solid tumor | Lei Xiao, He Sun, Wensheng Wang, Chengfei Pu, Li Mao | 2021-11-02 |
| 11104732 | Reducing immune inhibition induced by SIGLEC-15 | Chengfei Pu, Lei Xiao | 2021-08-31 |
| 10958749 | Method and device for pushing application message | Yun Yue, Yutian Tao, Mingjie Zhong, Wenhui WU, Haibo Bai | 2021-03-23 |
| 10918667 | Modified cell expressing therapeutic agent and uses thereof | Lei Xiao, Chengfei Pu | 2021-02-16 |
| 10869888 | Modified cell expansion and uses thereof | Lei Xiao, Chengfei Pu | 2020-12-22 |
| 10812607 | Method and device for pushing application message | Yun Yue, Yutian Tao, Mingjie Zhong, Wenhui WU, Haibo Bai | 2020-10-20 |
| 10793638 | Use of chimeric antigen receptor modified cells to treat cancer | Lei Xiao, Chengfei Pu, He Sun, Mao Bi, Zhao Wu | 2020-10-06 |